共 50 条
- [41] THROMBOLYSIS WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION - POTENTIALS AND PITFALLS JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 255 (02): : 237 - 239
- [42] THE RELATIVE BENEFIT AND RISKS OF INTRAVENOUS STREPTOKINASE AND TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION RISK/BENEFIT ANALYSIS FOR THE USE AND APPROVAL OF THROMBOLYTIC, ANTIARRHYTHMIC, AND HYPOLIPIDEMIC AGENTS, 1989, : 23 - 28
- [46] ENDOGENOUS TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND RISK OF MYOCARDIAL-INFARCTION LANCET, 1993, 341 (8854): : 1165 - 1168
- [48] HEPARIN AS ADJUNCTIVE THERAPY TO CORONARY THROMBOLYSIS IN ACUTE MYOCARDIAL-INFARCTION HEART & LUNG, 1995, 24 (04): : 292 - 304
- [49] HEMORRHAGIC COMPLICATIONS ASSOCIATED WITH THE USE OF INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR IN TREATMENT OF ACUTE MYOCARDIAL-INFARCTION AMERICAN JOURNAL OF MEDICINE, 1988, 85 (03): : 353 - 359
- [50] CARDIAC MORPHOLOGIC FINDINGS IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION TREATED WITH RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (15): : 953 - 961